Integra Therapeutics completes the €6-million seed round with the addition of Columbus Venture Partners

  • The biotechnology firm completes the seed round funding with a total of €6 million led last December by AdBio Partners, Invivo Capital and Takeda Ventures.
  • The Integra Therapeutics gene writing platform is one of the most promising in the world for improving gene therapy to treat genetic diseases and cancer.